Madrigal pharmaceuticals receives notice of allowance from u.s. patent and trademark office for new u.s. patent covering rezdiffra™ (resmetirom)

• provides protection through sept. 2044; will be listed in fda's orange book conshohocken, pa.

MDGL Ratings Summary

MDGL Quant Ranking